CEVEC NEWS

CYTIVA STRENGTHENS CELL LINE DEVELOPMENT WITH CEVEC ACQUISITION

  • Viral vector manufacturing and cell line development are keystone technologies in the making of gene therapies
  • 46 scientific experts based in Cologne, Germany, join the Cytiva team in the genomic medicine space
  • Cytiva customers will have immediate access to technologies that solve some of the greatest challenges in bringing gene therapies to patients

October 6, 2022

READ MORE
PRESS RELEASES
MEDIA LIBRARY

KEEP IN TOUCH

By clicking any of these options and submitting this form, you agree to receive marketing emails, newsletters and other promotional communications from Cytiva. You can withdraw your consent at any time, by clicking here. For more information please review our privacy policy.

© CEVEC Pharmaceuticals GmbH 2023